Cardiff Oncology Inc (CRDF) — Net Asset Quality Index
Cardiff Oncology Inc (CRDF) has a Net Asset Quality Index of 73.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $61.88 Million minus total liabilities of $16.50 Million yields net assets of $45.39 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read CRDF total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cardiff Oncology Inc Net Asset Quality Index Over Time (2009–2025)
This chart shows how Cardiff Oncology Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the index stands at 73.3%, representing net assets of $45.39 Million against total assets of $61.88 Million USD. For live market cap and overall valuation, see CRDF market cap overview.
Annual Net Asset Quality Index for Cardiff Oncology Inc (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for Cardiff Oncology Inc from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Cardiff Oncology Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.3% | $45.39 Million | $61.88 Million | $16.50 Million | ▼ -12.0 pp |
| 2024 | 85.3% | $82.95 Million | $97.19 Million | $14.24 Million | ▼ -0.1 pp |
| 2023 | 85.4% | $69.74 Million | $81.64 Million | $11.90 Million | ▼ -6.1 pp |
| 2022 | 91.5% | $106.34 Million | $116.19 Million | $9.85 Million | ▼ -2.4 pp |
| 2021 | 93.9% | $140.42 Million | $149.54 Million | $9.13 Million | ▼ -1.2 pp |
| 2020 | 95.1% | $128.16 Million | $134.73 Million | $6.57 Million | ▲ +39.3 pp |
| 2019 | 55.9% | $7.31 Million | $13.09 Million | $5.78 Million | ▼ -15.3 pp |
| 2018 | 71.2% | $10.08 Million | $14.17 Million | $4.09 Million | ▲ +18.2 pp |
| 2017 | 53.0% | $6.51 Million | $12.29 Million | $5.78 Million | ▲ +8.0 pp |
| 2016 | 45.0% | $19.77 Million | $43.95 Million | $24.18 Million | ▼ -23.2 pp |
| 2015 | 68.2% | $48.70 Million | $71.45 Million | $22.75 Million | ▲ +39.3 pp |
| 2014 | 28.9% | $8.35 Million | $28.90 Million | $20.55 Million | ▼ -46.2 pp |
| 2013 | 75.1% | $20.39 Million | $27.16 Million | $6.76 Million | ▲ +56.5 pp |
| 2012 | 18.6% | $2.17 Million | $11.66 Million | $9.50 Million | ▲ +425.7 pp |
| 2011 | -407.1% | $-4.23 Million | $1.04 Million | $5.27 Million | ▲ +568.1 pp |
| 2010 | -975.2% | $-5.00 Million | $512.22K | $5.51 Million | ▼ -476.5 pp |
| 2009 | -498.7% | $-3.79 Million | $760.00K | $4.55 Million | — |